Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Fortrea Holdings's share price for the quarter that ended in Mar. 2026 was €7.55. Fortrea Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 95 Mil. Therefore, Fortrea Holdings's market cap for the quarter that ended in Mar. 2026 was €714 Mil.
Fortrea Holdings's quarterly market cap
increased
from Sep. 2025 (€645 Mil) to Dec. 2025 (€1,331 Mil) but then
declined
from Dec. 2025 (€1,331 Mil) to Mar. 2026 (€714 Mil).
Fortrea Holdings's annual market cap
declined
from Dec. 2023 (€2,771 Mil) to Dec. 2024 (€1,624 Mil) and
declined
from Dec. 2024 (€1,624 Mil) to Dec. 2025 (€1,331 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Fortrea Holdings's Enterprise Value for Today is €2,303 Mil.
Fortrea Holdings (FRA:K67) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Fortrea Holdings Market Cap Related Terms
Fortrea Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Fortrea Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:K67 vs SEPN, MLTX, URGN: Market Cap Comparison
For the Biotechnology subindustry, Fortrea Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortrea Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Fortrea Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Fortrea Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortrea Holdings (FRA:K67) has a Market Cap of €1,451 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Fortrea Holdings and its competitors. According to the industry distribution chart, Fortrea Holdings ranks #209 out of 1421 companies in the Biotechnology industry, placing it in the top 14.7%.
Is Fortrea Holdings' Market Cap too high?
Fortrea Holdings' current Market Cap is €1,451 Mil. Based on the distribution chart, Fortrea Holdings ranks #209 out of 1421 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Fortrea Holdings has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Market Cap compare to SEPN and MLTX?
According to the Biotechnology industry distribution chart, Fortrea Holdings ranks #209 out of 1421 companies for Market Cap. This places Fortrea Holdings in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.57, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Fortrea Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 121.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortrea Holdings's current Market Cap is €1,451 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Fortrea Holdings (FRA:K67) has a current Market Cap of €1,451 Mil. The stock's GF Value™ is €14.91, compared to a current price of €15.30 — trading 2.6% above its estimated fair value. The current Market Cap is €1,451 Mil. Fortrea Holdings' overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Fortrea Holdings (FRA:K67), the current Market Cap is €1,451 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fortrea Holdings (FRA:K67) Overvalued in 2026?
Based on GuruFocus' analysis, Fortrea Holdings stock appears to be overvalued.
The current stock price of €15.30 is trading 2.6% above its estimated GF Value™ of €14.91.
Key valuation signals for FRA:K67:
Market Cap: €1,451 Mil
GF Value™: €14.91 vs. price of €15.30 (2.6% above fair value)
No single metric tells the full story. See the FRA:K67 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
64GF Score
Get the complete analysis for FRA:K67
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:K67 has been successfully added to your 
